Gemmer Asset Management LLC Repligen Corp Transaction History

Gemmer Asset Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$140.68 - $188.02 $7,315 - $9,777	-52 Closed	0 $0
Q4 2020 Jan 28, 2021	SELL	$148.08 - $206.57 $4,442 - $6,197	-30 Reduced 36.59%	52 $10,000
Q2 2020 Jul 31, 2020	BUY	$94.33 - $140.48 $2,829 - $4,214	30 Added 57.69%	82 $10,000
Q4 2019 Jan 17, 2020	SELL	$73.84 - $93.08 $2,362 - $2,978	-32 Reduced 38.1%	52 $5,000
Q3 2017 Oct 12, 2017	BUY	$36.98 - $46.06 $3,106 - $3,869	84	84 $3,000

489

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.91B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Gemmer Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Gemmer Asset Management LLC with notifications on news.